Too young for dementia? Think again—Symptoms that start earlier than you think
So, you misplaced your keys again. You walked into a room and forgot why. You can't find the word you're looking for, and suddenly you're wondering—wait, am I too young to be worried about dementia?
When we think of dementia, we usually picture silver-haired grandparents struggling with names or forgetting where they live.
But here's a curveball—dementia isn't just an old-age thing. Young-onset dementia, also called early-onset dementia, can affect people under 65, and in some rare cases, even those in their 30s or 40s. Yup, it's a thing. And no, you're not being dramatic by paying attention to the signs.
What is young-onset dementia?
Young-onset dementia is a form of cognitive decline that kicks in way before the typical age we associate with it. While Alzheimer's is the most well-known type of dementia, there are actually over 200 subtypes.
And early-onset can be triggered by a variety of things—from genetics to lifestyle to certain medical conditions.
Because it's rare, it's also wildly underdiagnosed. Many younger people experiencing symptoms are often misdiagnosed with depression, anxiety, or even stress-induced burnout. It's easy to shrug off early signs—after all, who expects dementia in their 30s?
But here's the kicker: by the time cognitive symptoms are obvious, the damage has already begun.
That's why early awareness is everything.
What dementia symptoms should you look out for?
Forgetfulness is a normal part of life, but there's a difference between spacing out and something more serious. Early dementia signs often sneak in like uninvited party guests. Here are a few red flags that might show up in younger adults:
1. Language troubles: Struggling to find everyday words or mixing up common phrases more often than usual. If you keep calling your toothbrush a 'mouth stick' or can't finish your sentences, that's worth noticing.
2. Behavior and mood shifts: Are you suddenly more irritable, anxious, or unusually withdrawn? Personality changes can be one of the earliest signs of frontotemporal dementia, which affects younger people more than other types.
3. Trouble with planning and organization: Missing appointments, struggling to manage your calendar, or messing up basic tasks at work might signal something deeper than distraction.
4. Spatial awareness issues: Bumping into furniture, misjudging distances while driving, or getting lost in familiar places—these are all signs that your brain might be struggling with navigation.
5. Memory loss that disrupts daily life: Everyone forgets things sometimes. But if you're forgetting important dates, repeating yourself often, or asking the same question over and over, it might be time to check in.
6. Problems at work: If your performance suddenly drops, you can't follow meetings, or you're overwhelmed by multitasking, it's not just about being 'bad at Zoom.' It could be cognitive decline.
Why is it so often missed?
Because it's not expected, plain and simple. Most people don't jump to dementia as a diagnosis when someone in their 30s or 40s walks in with memory problems. It's far more likely to be labeled as stress, anxiety, depression, ADHD, or even just lifestyle overload.
And while those are real and valid issues, they can sometimes mask the early symptoms of dementia.
Many people suffer in silence or go years without answers because their symptoms don't fit the age bracket. That's why it's so important to trust your instincts and advocate for a proper neurological evaluation if something feels off.
What causes early-onset dementia?
The causes are still being studied, but here are a few factors:
Genetics: If there's a strong family history of dementia, especially early-onset types, your risk may be higher.
Brain injuries: Head trauma can increase the risk of dementia, even years after the injury.
Lifestyle-related risks: Lack of exercise, poor diet, smoking, and alcohol abuse can all increase cognitive decline.
Underlying health conditions: Issues like multiple sclerosis, autoimmune disorders, or even infections can sometimes mimic or trigger dementia-like symptoms.
But sometimes, it's just bad luck with biology.
It doesn't always come with a clear cause.
What can you do about it?
First things first: Don't panic. Not all memory glitches mean you're headed for dementia. But if your symptoms are consistent, progressive, and affecting your daily life, it's time to speak with a neurologist or memory specialist.
And even if it's not dementia? That's still a win. You'll rule out serious causes and possibly discover other things that are treatable—like vitamin deficiencies, thyroid issues, or mental health conditions.
Plus, the earlier you get a diagnosis (if there is one), the more options you have in terms of treatment, lifestyle changes, and support systems. There's no cure yet for dementia, but early management makes a huge difference in slowing progression and preserving quality of life.
Dementia isn't just a 'later in life' problem
It can show up earlier than you think, and it doesn't always knock loudly. Sometimes it creeps in through confusion, disorganization, or personality shifts.
So if your brain's been feeling foggier than it should, don't brush it off as just another modern-life burnout moment. Pay attention. Ask questions. And most importantly, advocate for yourself.
The content in this article is intended for informational and educational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or a qualified healthcare provider before starting any diet, supplement, fitness, or health program.
One step to a healthier you—join Times Health+ Yoga and feel the change
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
an hour ago
- Business Wire
Publication in Alzheimer's & Dementia Elucidates Multimodal Mechanism of Action Underpinning Promising New Neuromodulation Therapy for Alzheimer's
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Sinaptica Therapeutics, Inc., a clinical-stage company leading the development of a new class of personalized neuromodulation therapeutics to treat Alzheimer's and other primary neurodegenerative diseases, today announced that a comprehensive review article published in the peer-reviewed journal Alzheimer's & Dementia: The Journal of the Alzheimer's Association delivers a landmark synthesis of evidence that positions repetitive transcranial magnetic stimulation (rTMS) as a scientifically grounded, non-invasive therapeutic strategy for Alzheimer's disease (AD). The publication, ' The Neurobiological Foundation of Effective Repetitive Transcranial Magnetic Brain Stimulation in Alzheimer's Disease,' was authored by a multidisciplinary team led by Sinaptica scientific co-founder Dr. Giacomo Koch of the Santa Lucia Foundation, University of Ferrara, and the Italian Institute of Technology. Drawing on foundational models and recent clinical and animal data, the article charts how rTMS modulates biological systems across multiple levels—molecular, cellular, synaptic, and network-wide—to address core mechanisms of neurodegeneration. 'Our goal with this publication is to consolidate the preclinical and clinical findings to explain why rTMS isn't just symptomatic—it is actually disease modifying. This gives us a foundational understanding of how stimulation protocols can directly modulate neurotransmission, reduce inflammation, enhance plasticity, and even promote clearance of toxic proteins,' said Giacomo Koch, MD, PhD, Sinaptica scientific co-founder, Neurologist, Professor of Physiology, University of Ferrara, and Director, Non-Invasive Brain Stimulation Laboratory, Santa Lucia Foundation. The publication reviews the evidence supporting the fundamental mechanisms of action of rTMS treatments in AD. rTMS exerts profound effects from the micro-molecular scale to the macro network-level scale. By engaging distinct pre- and post-synaptic structures within the stimulated neural network, it directly and indirectly influences various cellular and molecular components. These effects work together to stabilize and improve brain function through the following means: Strengthens Neuronal Structures - Upregulates neurotrophic factors e.g. BDNF, leading to neuronal structural changes e.g. via remodeling of dendritic spines. Strengthens Synapses - Modulates neurotransmitter circuits, both through increased production and sensitivity of dopaminergic-, glutamatergic-, and GABA-ergic pathways. Neuroinflammation - Mitigates neuroinflammation by reducing microglial activation and pro-inflammatory cytokines release e.g. by promoting glutamate reuptake. Amyloid - May counteract beta amyloid overproduction and toxic aggregation by interrupting a vicious cycle of hyperexcitability. Tau - Potentially reduces tau hyperphosphorylation and accumulation via the GSK-3β pathway. Clearance - Potentially increases glymphatic clearance of toxic proteins. All of the above mechanisms contribute to restoring network-wide excitation/inhibition imbalance, restoring LTP-like mechanisms of neuroplasticity, and enhancing large-scale connectivity. Authors of this definitive paper are Giacomo Koch (Experimental Neuropsychophysiology Lab, Department of Clinical and Behavioural Neurology, Santa Lucia Foundation IRCCS), Emiliano Santarnecchi (Gordon Center for Medical Imaging, Mass General Research Institute; Harvard Medical School), Harald Hampel (Sorbonne University, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital), Annibale Antonioni (Department of Neuroscience and Rehabilitation, University of Ferrara), and Alessandro Martorana (Memory Clinic, Department of Systems Medicine, University of Tor Vergata). 'Based on this new publication, repetitive transcranial magnetic stimulation (rTMS) targeting the precuneus in the brain's central Default Mode Network is an emerging element of precision medicine in neurology. Based on accumulating basic, translational, and clinical evidence, this standardized targeted non-invasive electro-magnetic brain stimulation will likely be part of the evolving clinical care landscape with different treatments and combinations,' said co-author Dr. Harald Hampel, a leading international brain researcher and Alzheimer's disease (AD) scientist. 'Further clinical studies are warranted to benefit the globally increasing population of AD patients.' As the field moves toward more personalized and mechanistically distinct Alzheimer's therapies, this review provides a vital reference point for researchers, clinicians, and innovators. It supports the integration of rTMS into a precision medicine framework that could transform how providers manage Alzheimer's—potentially shifting the paradigm from reactive care to proactive, highly tailored, connectome-level intervention, including combination therapies. 'We are beginning to see rTMS emerge as a safe, scalable precision medicine platform for Alzheimer's,' said Emiliano Santarnecchi, PhD, co-founder of Sinaptica Therapeutics, Associate Professor of Radiology & Neurology at Harvard Medical School, as well as Director, Precision Neuroscience & Neuromodulation Program and Director, Network Control Laboratory, at Massachusetts General Hospital in Boston, MA. 'This is not just about stimulating the brain—it's about rewiring disease-affected networks with intention and scientific precision.' The publication establishes the translational relevance of these findings, citing Phase 1 and 2 human trials in which targeted, neuronavigated rTMS protocols have boosted memory, stabilized cognitive performance, restored functional brain connectivity, and enhanced gamma rhythm activity—key markers of brain health. These protocols, particularly those focused on the Default Mode Network (DMN), are seen as promising interventions for mild cognitive impairment and Alzheimer's. 'This definitive reference illuminates an evolving paradigm shift away from simplistic linear 'nerve stimulation' toward the new and rapidly progressing field of 'network modulation,' said Ken Mariash, CEO of Sinaptica Therapeutics. 'This publication presents a higher order systems-level approach to how we think about and treat brain diseases. Sinaptica's nDMN therapy induces a cascade of network-wide effects that compound, ultimately restoring the exquisite balance of the networks involved in memory and cognition. In this new context, we can better understand how it was possible to achieve such strong and consistent clinical outcomes in previous Phase 2 trials in mild/moderate Alzheimer's patients. This important publication reinforces everything we're building at Sinaptica by elucidating the neurobiological mechanisms underlying our therapy and validating the importance of targeting the brain's network-level dysfunction with both precision and personalization.' About the SinaptiStim ® System The SinaptiStim ® System is an investigational new approach to treating Alzheimer's disease using non-invasive personalized precision neuromodulation. Calibrated to each individual's brain, the therapy is delivered in weekly 20-minute sessions in a recliner. The SinaptiStim system delivers safe, painless, customized neurostimulation technology targeting the Default Mode Network (DMN), an important brain network associated with episodic memory, introspection, and other cognitive functions. The technology was granted Breakthrough Device Designation by the FDA in 2022. The company is preparing for a pivotal randomized controlled clinical trial in mild-to-moderate Alzheimer's. In this trial, the treatment will be calibrated quarterly using TMS and EEG concurrently in combination with MRI-guided neuronavigation, which enables the SinaptiStim System to achieve customized precise repeatable targeting and safe-yet-effective dosage for each patient, tracking progress and adjusting over time to achieve the best possible individualized outcomes with its nDMN therapy. The pivotal trial will also be designed to determine the effects of SinaptiStim ® System on several biomarkers measuring beta amyloid, phosphorylated tau, neuroinflammation, and synaptic dysfunction. About Sinaptica Therapeutics Sinaptica Therapeutics is a clinical-stage neuromodulation therapeutics company leading the development of a new class of novel personalized therapeutics to revolutionize the treatment of Alzheimer's and other primary neurodegenerative diseases. The company utilizes a patented non-invasive approach to treating Alzheimer's via precision neurostimulation of a key brain network involved in memory, the Default Mode Network. Sinaptica's scientific co-founders pioneered research on this novel approach which a growing body of evidence indicates can slow disease progression. Sinaptica's mission is to bring a safe, effective, and non-invasive neuromodulation therapy to Alzheimer's patients that can help to significantly slow the progression of cognitive, functional, and behavioral decline. Learn more at and follow us on LinkedIn and X @SinapticaTX. The SinaptiStim ® System is for investigational use only. It has not been approved by the U.S. Food and Drug Administration and is not available for commercial sale in any geography.
The Irish Sun
2 hours ago
- The Irish Sun
The 2-second at-home test that can reveal your risk of 8 nasty conditions – including killer stroke and Alzheimer's
A TEST you can do at home in matter of seconds - with a bag of sugar, an air fryer or even a pet - could reveal your risk eight diseases. Do you have difficulty picking up an object weighing 5 kilograms after a certain age? Advertisement 1 Declining muscle strength is linked to a higher risk of dementia or stroke Credit: Getty If so, you run the risk of developing conditions such as chronic lung disease, arthritis, stroke and Alzheimer's disease, according to researchers from the University of Sharjah in the United Arab Emirates. As we get older, our muscles naturally weaken. Muscle and But the current tools used by doctors can be expensive, meaning only clinics can afford them. Advertisement Read more on Alzheimer's Researchers set out find a simpler and more accessible method of assessing muscle strength without the use of specialised tools - finding that objects lying around at home can also be reliable indicators. Professor Rizwan Qaisar, the study's first author, said: "Imagine you're at home, and you pick up a bag of groceries, maybe something that weighs about 5 kg - like a big bag of sugar or a small kitchen appliance. "If you find yourself struggling with that, it might seem like a small thing, but our research shows it could be a really important clue about your health." Scientists conducted their investigation using data from 51,536 adults from 15 countries who were aged 50 and older. Advertisement Most read in Health "We tracked them over time to see if their ability to lift 5 kg was connected to developing various health conditions in the future . What we found was quite significant," Prof Qaisar said. "People who reported difficulty lifting 5 kg had a significantly higher risk of experiencing a lower quality of life, higher rates of depression, chronic lung diseases, hip fractures, joint disorders, 10 second one leg stand test "Interestingly, this connection held regardless of their age or gender. "Our findings strongly suggest that this simple, everyday test could be a valuable early indicator of overall health and potential future health challenges." Advertisement Researchers conducted their study over a five year period. Participants were asked to report if they had any difficulty doing various everyday activities at the outset of the study, as well their age, gender and country of residence. Those who had one of the diseases in question at the start of the study were excluded from analysis. One of the activities was 'lifting or carrying weights over 5 kilos', which became the central point of the researchers' analysis. Advertisement "The 5kg threshold was selected due to its relevance to everyday household objects, such as a standard bag of sugar or all-purpose flour, an average house cat, an air fryer, a portable slow cooker, and the cast iron Dutch oven," they wrote. "Thus, the study provides a practical and accessible measure of muscle strength and overall health within the domestic environment." Ways to improve your strength A strength exercise is any activity that makes your muscles work harder than usual. This increases your muscles' strength, size, power and endurance. The activities involve using your body weight or working against a resistance. You should try to do two sessions or more of muscle strengthening exercises a week. Examples of muscle-strengthening activities include: Lifting weights Working with resistance bands Heavy gardening, such as digging and shovelling Climbing stairs Hill walking Cycling Dance Push-ups, sit-ups and squats Yoga Source: Study participants were also asked to fill out a quality of life questionnaire - which included such as 'how often do you think your age prevents you from doing the things you would like to do?' - and had symptoms of depression assessed too. From the 51,536 respondents, 10,025 (19.5 per cent) had difficulty lifting 5kg at the start of the study. Advertisement Over the follow-up period, researchers found that people who had difficulty picking up 5kg objects had a higher risk of reporting a low quality of life (9 per cent), depression (8 per cent) and osteoarthritis (7 per cent). They also had a mild to moderate risks of having "rheumatoid arthritis, heart attack, diabetes mellitus, Study authors found that women had a higher risk of various diseases than men. They said muscle weakness could be indicative of several things. Advertisement "First, muscle weakness in these participants suggests a sedentary lifestyle and low physical activity, which are risk factors for several diseases reported here. "For example, a sedentary lifestyle is associated with higher risks of depression, cardiovascular diseases, metabolic disorders, and neurological deficits. "Participants with difficulty lifting 5kg will likely exhibit muscle wasting," they went on. "Muscle mass is a significant protein reserve that protects against organ degeneration due to trauma, diseases, and/or ageing. Thus, a low muscle mass in the participants with difficulty lifting 5kg of weight can predispose them to develop chronic diseases." Advertisement Finally, muscle weakness could be connected to inflammation. "It is also established that chronic low-grade inflammation can cause and/or exacerbate various cardiovascular, neurological, and metabolic disorders reported in this study," researchers stated. Study co-author Dr Fabio Franzese from SHARE Berlin Institute in Germany, said: "Muscle weakness isn't just a sign of ageing; it's a profound warning for future disease." That's why the "simple act" of trying pick up 5kg with "no fancy equipment" can be "a powerful health predictor". Advertisement "Our findings put early health assessment in everyone's hands," he said. Prof Qaisar added: "Before major illness, there's often a subtle struggle. This test offers a crucial window for intervention. " The test empowers people to seek early medical advice, motivates healthier lifestyle choices, and offers health care providers a valuable preliminary screening tool to identify at-risk individuals, ultimately improving preventive care and public health outreach for older populations."
Time of India
5 hours ago
- Time of India
Too young for dementia? Think again—Symptoms that start earlier than you think
So, you misplaced your keys again. You walked into a room and forgot why. You can't find the word you're looking for, and suddenly you're wondering—wait, am I too young to be worried about dementia? When we think of dementia, we usually picture silver-haired grandparents struggling with names or forgetting where they live. But here's a curveball—dementia isn't just an old-age thing. Young-onset dementia, also called early-onset dementia, can affect people under 65, and in some rare cases, even those in their 30s or 40s. Yup, it's a thing. And no, you're not being dramatic by paying attention to the signs. What is young-onset dementia? Young-onset dementia is a form of cognitive decline that kicks in way before the typical age we associate with it. While Alzheimer's is the most well-known type of dementia, there are actually over 200 subtypes. And early-onset can be triggered by a variety of things—from genetics to lifestyle to certain medical conditions. Because it's rare, it's also wildly underdiagnosed. Many younger people experiencing symptoms are often misdiagnosed with depression, anxiety, or even stress-induced burnout. It's easy to shrug off early signs—after all, who expects dementia in their 30s? But here's the kicker: by the time cognitive symptoms are obvious, the damage has already begun. That's why early awareness is everything. What dementia symptoms should you look out for? Forgetfulness is a normal part of life, but there's a difference between spacing out and something more serious. Early dementia signs often sneak in like uninvited party guests. Here are a few red flags that might show up in younger adults: 1. Language troubles: Struggling to find everyday words or mixing up common phrases more often than usual. If you keep calling your toothbrush a 'mouth stick' or can't finish your sentences, that's worth noticing. 2. Behavior and mood shifts: Are you suddenly more irritable, anxious, or unusually withdrawn? Personality changes can be one of the earliest signs of frontotemporal dementia, which affects younger people more than other types. 3. Trouble with planning and organization: Missing appointments, struggling to manage your calendar, or messing up basic tasks at work might signal something deeper than distraction. 4. Spatial awareness issues: Bumping into furniture, misjudging distances while driving, or getting lost in familiar places—these are all signs that your brain might be struggling with navigation. 5. Memory loss that disrupts daily life: Everyone forgets things sometimes. But if you're forgetting important dates, repeating yourself often, or asking the same question over and over, it might be time to check in. 6. Problems at work: If your performance suddenly drops, you can't follow meetings, or you're overwhelmed by multitasking, it's not just about being 'bad at Zoom.' It could be cognitive decline. Why is it so often missed? Because it's not expected, plain and simple. Most people don't jump to dementia as a diagnosis when someone in their 30s or 40s walks in with memory problems. It's far more likely to be labeled as stress, anxiety, depression, ADHD, or even just lifestyle overload. And while those are real and valid issues, they can sometimes mask the early symptoms of dementia. Many people suffer in silence or go years without answers because their symptoms don't fit the age bracket. That's why it's so important to trust your instincts and advocate for a proper neurological evaluation if something feels off. What causes early-onset dementia? The causes are still being studied, but here are a few factors: Genetics: If there's a strong family history of dementia, especially early-onset types, your risk may be higher. Brain injuries: Head trauma can increase the risk of dementia, even years after the injury. Lifestyle-related risks: Lack of exercise, poor diet, smoking, and alcohol abuse can all increase cognitive decline. Underlying health conditions: Issues like multiple sclerosis, autoimmune disorders, or even infections can sometimes mimic or trigger dementia-like symptoms. But sometimes, it's just bad luck with biology. It doesn't always come with a clear cause. What can you do about it? First things first: Don't panic. Not all memory glitches mean you're headed for dementia. But if your symptoms are consistent, progressive, and affecting your daily life, it's time to speak with a neurologist or memory specialist. And even if it's not dementia? That's still a win. You'll rule out serious causes and possibly discover other things that are treatable—like vitamin deficiencies, thyroid issues, or mental health conditions. Plus, the earlier you get a diagnosis (if there is one), the more options you have in terms of treatment, lifestyle changes, and support systems. There's no cure yet for dementia, but early management makes a huge difference in slowing progression and preserving quality of life. Dementia isn't just a 'later in life' problem It can show up earlier than you think, and it doesn't always knock loudly. Sometimes it creeps in through confusion, disorganization, or personality shifts. So if your brain's been feeling foggier than it should, don't brush it off as just another modern-life burnout moment. Pay attention. Ask questions. And most importantly, advocate for yourself. The content in this article is intended for informational and educational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or a qualified healthcare provider before starting any diet, supplement, fitness, or health program. One step to a healthier you—join Times Health+ Yoga and feel the change
